Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (INBS) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Intelligent Bio Solutions Inc. (INBS), covering cash flow, earnings, and balance sheets.
Intelligent Bio Solutions Inc. (INBS) Income Statement & Financial Overview
Analyze Intelligent Bio Solutions Inc.’s INBS earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $728867.00 | $607494.00 | $872287.00 | $1.42M |
| Cost of Revenue | $387499.00 | $384381.00 | $525486.00 | $164017.00 |
| Gross Profit | $341368.00 | $223113.00 | $346801.00 | $1.26M |
| Gross Profit Ratio | $0.47 | $0.37 | $0.40 | $0.88 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $79274.00 |
| SG&A Expenses | $2.41M | $1.81M | $1.95M | $2.66M |
| Operating Expenses | $2.41M | $1.81M | $1.95M | $2.74M |
| Total Costs & Expenses | $2.80M | $2.19M | $2.47M | $2.91M |
| Interest Income | $17687.00 | $21937.00 | $52840.00 | $81085.00 |
| Interest Expense | -$15000.00 | -$13502.00 | -$22327.00 | -$35517.00 |
| Depreciation & Amortization | -$301978.00 | -$305177.00 | -$300422.00 | -$422667.00 |
| EBITDA | -$2.86M | -$2.57M | -$3.03M | -$3.58M |
| EBITDA Ratio | -$3.92 | -$4.23 | -$3.47 | -$2.52 |
| Operating Income | -$2.55M | -$2.26M | -$2.73M | -$2.96M |
| Operating Income Ratio | -$3.50 | -$3.73 | -$3.12 | -$2.08 |
| Other Income/Expenses (Net) | $9722.00 | $15012.00 | $39628.00 | -$165660.00 |
| Income Before Tax | -$2.54M | -$2.25M | -$2.69M | -$3.12M |
| Income Before Tax Ratio | -$3.49 | -$3.70 | -$3.08 | -$2.20 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$1.65M |
| Net Income | -$2.54M | -$2.25M | -$2.69M | -$1.48M |
| Net Income Ratio | -$3.49 | -$3.70 | -$3.08 | -$1.04 |
| EPS | -$0.44 | -$0.50 | -$0.70 | $1.00 |
| Diluted EPS | -$0.44 | -$0.50 | -$0.70 | $1.00 |
| Weighted Avg Shares Outstanding | $5.77M | $4.54M | $3.81M | $0.00 |
| Weighted Avg Shares Outstanding (Diluted) | $5.77M | $4.54M | $3.81M | $0.00 |
Over the past four quarters, Intelligent Bio Solutions Inc. demonstrated steady revenue growth, increasing from $1.42M in Q4 2024 to $728867.00 in Q3 2025. Operating income reached -$2.55M in Q3 2025, maintaining a consistent -350% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$2.86M, reflecting operational efficiency. Net income dropped to -$2.54M, with EPS at -$0.44. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan